Abpro: Funding, Investors & Team (Oct 2026)
Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds. Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.
Abpro has raised $2.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Nov 2024.
Abpro Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Abpro Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Abpro raised $2.0M in an undisclosed round announced in Apr 2022.
2.6 years later, an undisclosed round was announced in Nov 2024 with no disclosed amount.
Abpro Founders and Leadership Team
Contact details for the Abpro team: 1 of 2 have an email address on file.
Start 14-day free trial →Abpro Funding Compared to Other Biotechnology Startups
Funded Startups Like Abpro in Biotechnology and Woburn
Companies Similar to Abpro
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Abpro Funding FAQs
What does Abpro do?
Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds. Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.
How much funding has Abpro raised?
Abpro has raised $2.0M across 2 rounds on record.
When did Abpro last raise funding?
Abpro's most recent funding round on record was announced in Nov 2024. The amount was not disclosed.
Who founded Abpro?
FundedIQ lists Eugene Cha (Founder) at Abpro.
Who is the CEO of Abpro?
Ian Chan is listed as CEO at Abpro.
Where is Abpro headquartered?
Abpro is based in Woburn, Massachusetts, United States.
How many employees does Abpro have?
Abpro is in the 11-50 employee band.
About FundedIQ's Abpro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Abpro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.